Results 171 to 180 of about 8,379,611 (261)

Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update)

open access: yesMycoses, Volume 69, Issue 9, September 2026.
ABSTRACT Background Central nervous system (CNS) aspergillosis is a life‐threatening infection with mortality rates exceeding 50%, especially in immunocompromised patients. Significant challenges persist due to limited antifungal drug penetration into the CNS, emerging resistance, and diagnostic delays, despite advancements in therapy and diagnostics ...
Moustafa A. Mansour   +5 more
wiley   +1 more source

User and Provider Experiences with a Digital Health Family Planning Counseling Tool for Women Living with HIV in Kenya

open access: yesStudies in Family Planning, Volume 57, Issue 3, Page 371-389, September 2026.
Abstract Women living with HIV(WLHIV) have diverse and complex reproductive health needs that require patient‐centered, informed decision‐making. Digital tools to support reproductive life planning may improve reproductive health counseling and outcomes for these women.
Agnes Karingo Karume   +8 more
wiley   +1 more source

Co‐Occurring Risk Factors for Tuberculosis Preventive Treatment Non‐Adherence Among People Living With HIV in Ethiopia: A Latent Class Analysis

open access: yesTropical Medicine &International Health, Volume 31, Issue 9, Page 1250-1260, September 2026.
ABSTRACT Objective Non‐adherence to tuberculosis preventive treatment (TPT) among people living with HIV (PLHIV) is a critical issue in Ethiopia and other Sub‐Saharan African countries, where both TB and HIV burdens are high. To reduce TPT non‐adherence among PLHIV, it is crucial to identify those at risk and implement targeted interventions. Therefore,
Edao Sinba Etu   +5 more
wiley   +1 more source

Targeting Human Immunodeficiency Virus Integrase Beyond the Active Site: The Discovery and Development of Allosteric Integrase Inhibitors

open access: yesChemMedChem, Volume 21, Issue 16, 27 August 2026.
Human immunodeficiency virus (HIV) allosteric integrase inhibitors (ALLINIs) offer a vital alternative to standard therapies by targeting noncatalytic sites. By inducing aberrant integrase multimerization, they disrupt viral maturation. This review explores their medicinal chemistry evolution, detailing structural insights, structure–activity ...
Francesco Saccoliti   +10 more
wiley   +1 more source

Highly Active Antiretroviral Therapy (HAART) - "Sulfonyl", and anal cancer outcomes from patients living with HIV: a retrospective cohort. [PDF]

open access: yesInfect Agent Cancer
Miranda RR   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy